SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $347 | -53.9% | 579 | 0.0% | 0.00% | – |
Q2 2023 | $753 | -57.5% | 579 | -42.5% | 0.00% | – |
Q1 2023 | $1,772 | -56.9% | 1,007 | -23.0% | 0.00% | – |
Q4 2022 | $4,107 | -78.4% | 1,308 | -66.3% | 0.00% | – |
Q3 2022 | $19,000 | +46.2% | 3,879 | +23.7% | 0.00% | – |
Q2 2022 | $13,000 | -43.5% | 3,135 | -20.9% | 0.00% | – |
Q1 2022 | $23,000 | +666.7% | 3,963 | +771.0% | 0.00% | – |
Q4 2021 | $3,000 | -25.0% | 455 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 455 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | -16.7% | 455 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -14.3% | 455 | 0.0% | 0.00% | – |
Q4 2020 | $7,000 | +75.0% | 455 | 0.0% | 0.00% | – |
Q3 2020 | $4,000 | 0.0% | 455 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | -66.7% | 455 | -76.7% | 0.00% | – |
Q1 2020 | $12,000 | +200.0% | 1,955 | +329.7% | 0.00% | – |
Q4 2019 | $4,000 | 0.0% | 455 | 0.0% | 0.00% | – |
Q3 2019 | $4,000 | -20.0% | 455 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | +25.0% | 455 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | -20.0% | 455 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -37.5% | 455 | 0.0% | 0.00% | – |
Q3 2018 | $8,000 | +33.3% | 455 | 0.0% | 0.00% | – |
Q2 2018 | $6,000 | -33.3% | 455 | 0.0% | 0.00% | – |
Q1 2018 | $9,000 | +200.0% | 455 | +5.3% | 0.00% | – |
Q2 2016 | $3,000 | 0.0% | 432 | -3.8% | 0.00% | – |
Q1 2016 | $3,000 | -25.0% | 449 | +3.7% | 0.00% | – |
Q4 2015 | $4,000 | +100.0% | 433 | 0.0% | 0.00% | – |
Q3 2015 | $2,000 | -98.8% | 433 | -97.0% | 0.00% | – |
Q2 2015 | $162,000 | -28.3% | 14,600 | +1.9% | 0.00% | – |
Q1 2015 | $226,000 | -45.3% | 14,328 | -47.4% | 0.00% | – |
Q4 2014 | $413,000 | +40.5% | 27,228 | 0.0% | 0.00% | – |
Q3 2014 | $294,000 | +9700.0% | 27,228 | +11842.1% | 0.00% | – |
Q2 2014 | $3,000 | -25.0% | 228 | +15.2% | 0.00% | – |
Q1 2014 | $4,000 | -99.3% | 198 | -99.5% | 0.00% | -100.0% |
Q4 2013 | $562,000 | +32.5% | 40,500 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $424,000 | – | 40,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |